Litigation Finance:
The High-Yield Alternative Asset
Built on Discounted Settlement Claims
A plaintiff with a $180,000 personal injury case needs $18,000 today to cover rent and medical bills while the case runs for 22 months. A litigation funder provides that $18,000 in exchange for $45,000 at settlement — a 2.5x return in under two years, non-recourse, uncorrelated to equity markets, collateralized by a probable legal recovery. Annualized, that is a 58% gross IRR on a secured contractual right. This is not a fringe market. Burford Capital manages over $6 billion in active legal assets. YieldStreet has allocated hundreds of millions to litigation finance pools. LexShares has funded over $100 million in commercial litigation claims. This is the complete mathematical framework for understanding, modeling, and investing in it.
1. What Litigation Finance Actually Is — The Two Distinct Market Segments
Litigation finance is not one market. It is two markets with fundamentally different risk profiles, return characteristics, investor access requirements, and operational mechanics. Conflating them produces a distorted picture of the asset class. Precision on which segment you are investing in is the first requirement for credible due diligence.
The first segment is consumer pre-settlement funding — also called lawsuit loans, settlement advances, or legal funding. A plaintiff in a personal injury, workers’ compensation, or civil rights case receives a cash advance against their expected settlement. The advance is non-recourse. The funder takes no equity in the plaintiff, no lien on real property, and no right of collection if the case is lost. The funder’s entire return is contingent on a successful recovery. This segment generates the highest gross IRRs in the asset class — 30% to 100%+ annualized on individual transactions — precisely because the underwriting risk is highest, the case-level loss rates are highest, and the portfolio requires the most diversification to produce stable net returns.
The second segment is commercial litigation finance — funding corporate plaintiffs, law firms on contingency, and international arbitration proceedings. Here the funded amounts are larger ($500,000 to $100 million+), the cases are more complex, the due diligence process is more rigorous, and the return profile is lower-volatility. Loss rates in institutional commercial litigation portfolios run 8% to 15%. Gross IRRs run 18% to 28%. This is the segment that Burford Capital, Bentham IMF (now Omni Bridgeway), and Longford Capital operate in, and it is increasingly where family office and institutional capital is being allocated.
2. The Non-Recourse Funding Mechanics: How the Transaction Is Structured
Understanding the legal and financial structure of a pre-settlement funding transaction is essential before modeling its yield. The structure is simple in outline and deceptively nuanced in practice — particularly around the enforceability of funding agreements across different state legal environments.
The “purchase vs. loan” characterization is the central legal fault line of the entire industry. Courts in different states have reached conflicting conclusions. New York and most other states have generally upheld the purchase characterization, allowing funders to enforce payback terms without usury law constraints. A minority of states have reclassified pre-settlement funding as loans, applying usury caps that make the economics unworkable for funders and effectively removing the product from those markets. For investors evaluating a litigation finance fund, the geographic concentration of the portfolio and the legal characterization treatment in each target state is a material due diligence item.
3. The IRR Mathematics: How Duration Destroys and Creates Value
The most important concept in litigation finance investing is the relationship between MOIC (multiple of invested capital) and IRR, mediated by case duration. A funding agreement that specifies a 2.5x payback cap — meaning the funder receives $45,000 for a $18,000 advance — sounds like a fixed return. It is not. The annualized IRR on that same 2.5x MOIC swings from 58% to 16% depending entirely on how long the case takes to resolve. Case duration is the single variable that most directly determines whether a litigation finance investment delivers outsized returns or disappointing ones.
Gross IRR by MOIC and Case Duration — Litigation Finance Single-Case Economics
4. Portfolio Loss Rate Modeling: The Actuarial Engine Under the Yield
The gross IRR numbers above are pre-loss figures. Every litigation finance portfolio carries a case-level binary risk that gross return calculations ignore: any individual case can result in zero recovery. The plaintiff loses at trial, the case is dismissed on summary judgment, the defendant files bankruptcy, or the settlement amount is insufficient to cover the funding payback after attorney fees. Each of these outcomes returns exactly zero to the funder on that specific investment. Portfolio loss rate modeling is the discipline that converts spectacular single-case gross IRRs into credible net return projections.
The implication of the loss rate sensitivity analysis is counterintuitive: litigation finance is a more forgiving risk model than it appears. Because the non-loss cases deliver such high gross returns (50%+), the portfolio can absorb loss rates that would be catastrophic in a credit portfolio — where a 35% default rate would produce deeply negative returns — and still deliver superior net performance. The non-recourse structure compresses the loss severity to exactly zero on failed cases while preserving the full upside on winning cases. This asymmetric loss profile is the structural feature that makes litigation finance genuinely different from other high-yield alternatives, not just higher-yielding credit.
Model a Settlement Funding Transaction’s IRR and Net Yield
Run any pre-settlement funding advance amount, payback multiple, expected duration, and portfolio loss rate through our Personal Injury Settlement Calculator to generate the gross IRR, net IRR, and 5-year portfolio compounding curve for your litigation finance allocation model.
5. The Pre-Settlement Funding Arbitrage: Where the Funder’s Edge Comes From
The word “arbitrage” is used loosely in finance, but it describes the litigation funding dynamic precisely. The funder acquires a contractual right to a future cash flow — the settlement proceeds — at a discount to its expected value. The discount is created by the plaintiff’s immediate liquidity need, their inability to borrow against the contingent asset through conventional credit channels, and the asymmetric information advantage the funder develops through systematic case underwriting. Each of these three factors is durable and structural, not circumstantial.
Dissecting the Funder’s Edge on a $180,000 Expected Settlement Value Case
The information asymmetry dimension of this arbitrage is worth dwelling on. A sophisticated litigation funder who has underwritten 5,000 personal injury cases develops a statistical model of recovery probability that is more accurate than any individual plaintiff’s assessment of their own case. The plaintiff, advised by an attorney incentivized to take the case on contingency, typically has an optimistic view of recovery probability. The funder, applying actuarial discipline to a large historical dataset, prices the recovery probability more conservatively — which is why the funder’s advance is set at 10% to 25% of ESV rather than 50% or 75%. The gap between the plaintiff’s perception of case strength and the funder’s actuarial pricing is the information edge that makes the arbitrage durable.
6. Commercial Litigation Finance: Higher Minimums, Lower Volatility, Institutional Grade
The consumer pre-settlement segment generates the highest gross IRRs in the asset class, but it comes with operational complexity, regulatory variability, and portfolio management overhead that makes it primarily accessible through fund vehicles rather than direct investment. Commercial litigation finance — funding corporate plaintiffs in patent litigation, securities fraud claims, breach of contract disputes, and international arbitration — operates on a different scale and offers family office investors a cleaner entry point with lower portfolio volatility.
| Dimension | Consumer Pre-Settlement | Commercial Litigation Finance |
|---|---|---|
| Typical case size | $5,000–$500,000 advance per case | $500,000–$100M+ per case |
| Case type | Personal injury, auto accidents, slip-and-fall, workers’ comp | Patent, securities, breach of contract, international arbitration, antitrust |
| Case-level loss rate | 15–30% | 8–15% |
| Gross IRR range (single case) | 30–100%+ annualized | 18–28% annualized |
| Typical case duration | 12–36 months | 24–72 months |
| Minimum investor access | $2,500–$10,000 (via platform funds) | $250,000–$5M (institutional funds) |
| Regulatory environment | State-by-state patchwork; some hostile jurisdictions | Generally unregulated; contract law only |
| Publicly traded access | No direct public market | Burford Capital (NYSE: BUR), Omni Bridgeway (ASX: OBL) |
| Primary investor audience | Accredited investors via pooled funds | Family offices, institutional LPs, sovereign wealth |
| Market size (US, estimated 2025) | $3–4B annual volume | $13–17B annual deployed capital |
7. Platform-by-Platform Analysis: LexShares, Burford, YieldStreet
Accredited investors and family offices have three distinct pathways into litigation finance: direct platform investing, publicly traded equity in litigation finance firms, and institutional fund allocation. Each pathway offers a different combination of minimum investment, liquidity, portfolio transparency, and return profile. The right pathway depends on portfolio size, desired involvement level, and tolerance for illiquidity.
Direct Commercial Litigation Investment Platform
Publicly Traded Institutional Litigation Finance — Equity Access
Pooled Litigation Finance Allocation for Accredited Investors
8. The Real Risk Factors: What the Yield Doesn’t Tell You
Litigation finance’s high yield and non-correlation characteristics are genuine. The risks embedded in the asset class are also genuine, and several of them are systematically underweighted by investors encountering the asset class for the first time. Running the IRR math is step one. Understanding where the IRR model breaks down is step two.
| Risk Factor | Severity | Probability | Mitigation |
|---|---|---|---|
| Single-case binary loss (zero recovery) | Complete capital loss on that case | 15–30% per case | Portfolio diversification across 20+ uncorrelated cases; actuarially reduces to manageable expected loss rate |
| Case duration extension | IRR compression — no capital loss | High — litigation routinely extends beyond forecast | Model conservative duration assumptions (36 months vs. 24 months); underwrite MOIC to deliver acceptable IRR at longer duration |
| Settlement shortfall (recovery below ESV) | Partial recovery — payback cap may not be fully satisfied | Moderate — 20–35% of cases settle below ESV | Set advance at 10–15% of ESV rather than 25%; payback cap absorbs moderate settlement shortfalls |
| Regulatory reclassification (loan vs. purchase) | Usury cap enforcement; payback terms unenforceable; regulatory action | Low to moderate — currently jurisdictionally contained | Geographic diversification; avoid states with actively hostile regulatory environments; institutional commercial funding largely immune |
| Plaintiff attorney misconduct or bankruptcy | Loss of lien enforcement; malpractice risk | Low — attorney ethics obligations and bar oversight | Attorney lien acknowledgment at origination; use established contingency firms with documented track records |
| Adverse precedent (case law shift) | Portfolio-wide effect on cases in specific legal theory | Low but correlated — can affect multiple cases simultaneously | Diversify across legal theories and case types; commercial litigation less vulnerable than consumer personal injury to single precedent shifts |
| Manager selection risk (fund vehicles) | Underperformance; fraud; misallocation | Low to moderate — varies by manager | Due diligence on manager’s historical portfolio IRR, loss rates, audited financial statements, and team track record |
9. Tax Treatment of Litigation Finance Returns: What the IRS Says
The tax treatment of litigation finance returns is not fully settled law, and the ambiguity is material for after-tax return modeling. Different transaction structures produce different tax outcomes, and investors should model after-tax returns before making allocation decisions rather than discovering the tax treatment at year-end.
For direct pre-settlement funding investments structured as purchases of contingent assets, the IRS has generally treated the investor’s profit (the excess of payback received over the amount advanced) as ordinary income in the year of receipt — not as capital gains. This is the most conservative and most commonly applied treatment by tax professionals, and it results in the investor’s return being taxed at the marginal ordinary income rate (up to 37% federal) rather than the preferential long-term capital gains rate (23.8% including NIIT). The ordinary income treatment, if applied, reduces the after-tax IRR meaningfully — a 58% gross IRR in a 37% marginal bracket becomes approximately 36.5% after-tax on the pre-loss gain component.
10. The Due Diligence Framework: What to Ask Before Allocating
Litigation finance is an opaque asset class by nature — case details are confidential, settlement amounts are often sealed, and portfolio-level performance data is not subject to standardized public reporting. The information asymmetry that creates the funder’s arbitrage edge also creates an information disadvantage for outside investors evaluating a fund manager or platform. The due diligence checklist below is the minimum standard for any allocation above $50,000.
Litigation Finance Fund or Platform: 12 Questions Before Committing Capital
11. Portfolio Construction: Sizing the Litigation Finance Sleeve
Litigation finance earns its place in a sophisticated portfolio not just for its yield but for what it does to portfolio-level risk-adjusted returns. Because the asset class has near-zero correlation to equities and credit, even a modest allocation — 5% to 15% of a total alternative assets sleeve — can meaningfully improve the Sharpe ratio of the broader portfolio without adding directional market exposure. The question is not whether to allocate but how to size and structure the sleeve given liquidity constraints and investment minimums.
Calculate the IRR and Terminal Value of Your Litigation Finance Allocation
Our Personal Injury Settlement Calculator models any pre-settlement funding advance, payback multiple, expected case duration, and portfolio loss rate — generating the gross IRR, portfolio net IRR after losses, and 5-year compounding curve for your alternative investment analysis. Run the numbers before your next allocation meeting.
Model My Litigation Finance IRR →Frequently Asked Questions: Litigation Finance Investment Yield
Litigation finance is the practice of a third-party investor providing capital to a plaintiff or law firm in exchange for a contractually defined share of the future settlement or judgment proceeds. The investment generates yield through the spread between the amount funded and the investor’s contractual return — typically structured as a multiple of invested capital (MOIC) of 1.5x to 3.0x, or as an annualized IRR of 15% to 35% depending on case type, duration, and risk profile. The funding is non-recourse: if the case is lost or dismissed with no recovery, the investor receives nothing and cannot pursue the plaintiff for repayment. The yield is earned by pricing that binary win/lose outcome risk into the funding discount at origination — the same actuarial discipline that underlies insurance underwriting.
Gross annualized IRR on individual litigation finance cases ranges from 15% to 100%+ depending on MOIC and case duration. At the portfolio level, after absorbing the 15% to 30% case-level loss rate and 1.5% to 2.5% annual management fees, net portfolio IRRs for well-managed consumer pre-settlement funds range from 20% to 38% annualized. Institutional commercial litigation finance funds — targeting larger cases with lower loss rates of 8% to 15% — deliver net portfolio IRRs of 14% to 22%. The non-recourse structure means the loss rate on failed cases is complete capital loss on those positions but zero effect on winning cases, producing an asymmetric return profile that outperforms most fixed-income and private credit alternatives even at moderate loss rates.
In a pre-settlement funding transaction, the funder advances cash — typically $5,000 to $500,000 — in exchange for a contractual right to receive a specified multiple of that amount from settlement proceeds. Repayment is contingent solely on a successful recovery; there is no personal liability to the plaintiff if the case is lost. The funder prices the advance at 10% to 25% of the Expected Settlement Value (ESV), setting a payback cap of 1.5x to 3.0x the advance. If a case has an ESV of $120,000 and the funder advances $15,000 at a 2.5x payback cap, the funder receives $37,500 at settlement — a $22,500 gross profit. The annualized IRR at 18 months resolution is approximately 82%. At 36 months, the same 2.5x MOIC produces approximately 36% IRR. Duration is the primary IRR variable; MOIC is the secondary variable.
Case-level loss rates in consumer pre-settlement funding portfolios run 15% to 30%; commercial litigation portfolios run 8% to 15%; institutional arbitration and patent portfolios run 8% to 12%. These loss rates are managed through two mechanisms: underwriting discipline at origination (advancing only 10–15% of ESV to build a loss buffer) and portfolio diversification across 30 or more uncorrelated cases. Because winning cases deliver 1.5x to 3.0x+ returns and losing cases deliver exactly zero (not negative), the portfolio can absorb loss rates of up to 40% to 50% and still deliver positive net returns — a structural resilience that does not exist in conventional credit or equity portfolios where losses can exceed the original investment.
Accredited investors can access litigation finance through three channels: (1) LexShares — direct commercial litigation case investment with $2,500 minimum per case; (2) YieldStreet — pooled litigation finance fund products with $10,000 minimum, providing built-in diversification; and (3) Burford Capital (NYSE: BUR) — publicly traded equity in the world’s largest litigation finance firm, with no minimum investment and daily liquidity but equity market correlation. Family offices and investors with $250,000+ to allocate should also evaluate direct fund commitments to institutional managers including Longford Capital and Parabellum Capital. All direct and fund investments require accredited investor status at minimum; institutional funds require qualified purchaser status ($5M+ investable assets).
Yes — at the portfolio level, direct litigation finance returns have near-zero measured correlation to equity market indices. Legal claim outcomes are determined by case facts, applicable law, jury composition, and judicial assignment — none of which have any mechanical relationship to Federal Reserve policy, credit spreads, earnings cycles, or equity valuations. A stock market correction does not reduce the probability that a TBI plaintiff recovers damages, nor does it affect whether a patent was infringed. This structural non-correlation is the asset class’s most durable characteristic and the primary reason institutional allocators use it as a genuine portfolio diversifier rather than as a high-yield credit substitute. The one caveat is Burford Capital stock (NYSE: BUR), which does correlate with equity markets because it is an equity security — direct fund and platform investments do not carry this correlation.
The IRS has generally treated returns from pre-settlement funding structured as purchases of contingent assets as ordinary income in the year of receipt — taxable at the investor’s marginal rate (up to 37% federal), not at preferential capital gains rates. Some tax practitioners argue for capital gains treatment on the grounds that a legal claim is a capital asset under IRC Section 1221, but this position lacks controlling IRS guidance or Tax Court authority and carries meaningful audit risk. For after-tax IRR modeling, conservative practice is to apply ordinary income rates to the full gain. On a 58% gross IRR at the 37% marginal rate, the after-tax IRR is approximately 36.5% — which still substantially exceeds most alternative income vehicles on an after-tax basis. Consult a qualified tax attorney before finalizing your investment structure.
What is litigation finance and how does it generate investment yield?
Litigation finance is the practice of a third-party investor providing capital to a plaintiff or law firm in exchange for a contractually defined share of the future settlement or judgment proceeds. The investment generates yield through the difference between the amount funded and the investor’s contractual return — typically structured as a multiple of invested capital (MOIC) of 1.5x to 3.0x, or as an annualized IRR of 15% to 35% depending on case type, duration, and risk profile. The funding is non-recourse: if the case is lost or dismissed with no recovery, the investor receives nothing and cannot pursue the plaintiff for repayment. The yield is earned by pricing that binary outcome risk — win/recover versus lose/zero — into the funding discount at origination.
What is the IRR on litigation finance investments?
Annualized IRR on litigation finance investments ranges from 15% to 35% for single-case consumer funding and 18% to 28% for commercial litigation and arbitration funding, based on published data from Burford Capital, Bentham IMF, and portfolio studies cited in the Journal of Alternative Investments. The IRR is highly sensitive to case duration: a 2.0x MOIC on a 12-month case produces a 100% gross IRR, while the same 2.0x MOIC on a 36-month case produces a 26% annualized IRR. Portfolio-level IRRs after loss rates and management fees typically range from 12% to 22% net for institutional-grade litigation finance funds, placing the asset class above most fixed income and real estate debt alternatives on a risk-adjusted return basis when properly diversified.
